HH-321 is a novel phytotherapeutic supplement formulated to mimic and enhance the effects of ipamorelin through a synergistic blend of phytotherapeutic extracts. This white paper presents a comprehensive review of HH-321’s formulation, mechanistic pathways, and potential clinical benefits in the context of aging and metabolic disorders.
Seven evidence-backed phytptherapeutics – Mucuna pruriens, Withania somnifera (ashwagandha), fenugreek, Rhodiola rosea, Panax ginseng, Astragalus membranaceus, and Ginkgo biloba – are combined in specific ratios to promote GH release, support lean muscle mass, improve recovery, and enhance sleep quality. Each ingredient contributes unique bioactive compounds (L-DOPA, withanolides, saponins, rosavins, ginsenosides, astragalosides, flavone glycosides) that target neuroendocrine or metabolic pathways associated with GH regulation.
